发明授权
- 专利标题: Glycine transporter-inhibiting substances
- 专利标题(中): 甘氨酸转运蛋白抑制物质
-
申请号: US14000261申请日: 2012-02-21
-
公开(公告)号: US08796272B2公开(公告)日: 2014-08-05
- 发明人: Minoru Moriya , Hiroshi Ohta , Shuji Yamamoto , Kumi Abe , Yuko Araki , Xiang-Min Sun , Daisuke Wakasugi
- 申请人: Minoru Moriya , Hiroshi Ohta , Shuji Yamamoto , Kumi Abe , Yuko Araki , Xiang-Min Sun , Daisuke Wakasugi
- 申请人地址: JP Tokyo
- 专利权人: Taisho Pharmaceutical Co., Ltd
- 当前专利权人: Taisho Pharmaceutical Co., Ltd
- 当前专利权人地址: JP Tokyo
- 代理机构: Sughrue Mion, PLLC
- 优先权: JP2011-035169 20110221
- 国际申请: PCT/JP2012/054110 WO 20120221
- 国际公布: WO2012/115097 WO 20120830
- 主分类号: A61K31/50
- IPC分类号: A61K31/50 ; A61K31/501
摘要:
The present invention relates to novel compounds of formula [I] or pharmaceutically acceptable salts thereof: The compounds of the present invention are useful in the prevention or treatment of diseases such as schizophrenia, Alzheimer's disease, cognitive impairment, dementia, anxiety disorders (e.g., generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, social anxiety disorder, post-traumatic stress disorder, specific phobias, acute stress disorder), depression, drug dependence, spasm, tremor, pain, Parkinson's disease, attention deficit hyperactivity disorder, bipolar disorder, eating disorder, or sleep disorders, which is based on the glycine uptake-inhibiting action.
公开/授权文献
- US20130331571A1 GLYCINE TRANSPORTER-INHIBITING SUBSTANCES 公开/授权日:2013-12-12
信息查询